On the other hand, the use of a peptide designed to inhibit SAP97‐mediated ADAM10 trafficking to the synapse (Marcello et al., 2007) normalizes ADAM10 activity and rescues cognitive deficits in HD mice (Vezzoli et al., 2019). Here, ADAM10 is linked to Huntington disease.